Bausch + Lomb previewed a forthcoming product and pointed to company-funded research showing treatment effects possible after two, four and eight weeks of daily use.

Miebo, previously known as NOV03, aims to ease signs and symptoms in as few as 15 days by reducing tear evaporation, the company says.

B+L says that the solution matches the pH of healthy tears.

Diameter, base curve, axis and power can be tailored to fit patients with varying types of refractive error.

The company says the pH-balanced blend of nature-inspired ingredients works to improve comfort for contact lens wearers.